Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2025-06-16 | Forward | 38:1 |
Regencell Bioscience, founded in 2014 and based in Hong Kong, develops and commercializes Traditional Chinese Medicine for neurocognitive disorders like ADHD and autism spectrum disorder.

The company develops three liquid TCM formulations targeting mild to severe ADHD and ASD, focusing on neurocognitive disorders based on their proprietary 'Sik-Kee Au TCM Brain Theory™'.
Overall rating: C-
| PEER | PRICE | |
|---|---|---|
AXSM | $207.77 | COMPARE |
CYTK | $76.84 | COMPARE |
ATR | $134.80 | COMPARE |
ABVX | $114.95 | COMPARE |
RYTM | $110.00 | COMPARE |
GRFS | $8.00 | COMPARE |
STVN | $22.60 | COMPARE |